Search results
Redefining cancer therapy with photoimmunotherapy
Nature· 4 days agoClinical trials are under way for a new antibody-based anticancer platform called photoimmunotherapy (PIT), which has shown promise in selectively...
New test can predict if prostate cancer will come back
Daily Mail· 4 days agodefine that the worst 20 per cent of patients really did very badly compared the remainder which is...
Antigen processing by the proteasome - Nature Reviews Molecular Cell Biology
Nature· 4 days agoThe proteasome is an essential part of our immune surveillance mechanisms: by generating peptides from intracellular antigens it provides peptides that are then 'presented ...
Daily Mail analyzes fast food menus to reveal the most processed meals
Daily Mail· 3 days agoThere is still some debate around what is defined as 'ultra processed' - considered the most...
Column: Investing through index funds is more popular than ever, so why is it becoming...
LA Times via Yahoo Finance UK· 6 days agoA company that allows racial discrimination to reign on its factory floors is asking for regulatory...
Immunity Ruling Leaves Judge Facing Tough Calls on Trump’s Election Indictment
The New York Times via Yahoo News UK· 7 days agoAt some point soon, the Supreme Court’s ruling on presidential immunity will land back with the...
ResponderID: the future of predictive biomarker discovery is now
Nature· 4 days agoThe promise of targeted cancer therapies relies on ensuring that they reach the right patients: those with the tumor-associated biological changes targeted by a given therapeutic. Achieving ...
What is burnout? The symptoms, causes and solutions
Daily Telegraph· 5 days agoIt wasn’t until 2019 that the World Health Organisation defined it as an occupational syndrome that arises as a result of unsuccessfully managed stress...
Abivax Provides Operational and Key Program Update
PharmiWeb· 19 hours agoEQS-News: ABIVAX / Key word(s): MiscellaneousAbivax Provides Operational and Key Program Update 15.07.2024 / 22:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax ...
Tapping into MAGE potential to develop next-generation cancer therapies
Nature· 4 days agoBiotech company APO-T is developing bispecific T cell engagers (BiTEs) that facilitate the attraction of immune effector cells exclusively to cancer sites by targeting cancer ...